<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-96027" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Central Serous Chorioretinopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gupta</surname>
            <given-names>Abhishek</given-names>
          </name>
          <aff>IGIMS</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tripathy</surname>
            <given-names>Koushik</given-names>
          </name>
          <aff>ASG Eye Hospital, BT Road, Kolkata, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abhishek Gupta declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Koushik Tripathy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-96027.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Central serous chorioretinopathy is a retinal disorder characterized by localized serous detachment of the macula. It is secondary to retinal pigment epithelial decompensation and choroidal vascular changes. Most of the cases resolve spontaneously and gain normal vision. Some cases are non-resolving and require treatment. Such chronic cases, if not treated, will lead to permanent loss of vision. This activity reviews the evaluation and treatment of central serous chorioretinopathy and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the etiology of central serous chorioretinopathy.</p></list-item><list-item><p>Explain the typical presentation of central serous chorioretinopathy.</p></list-item><list-item><p>Review the typical imaging findings and treatments associated with central serous chorioretinopathy.</p></list-item><list-item><p>Summarize the importance of collaboration and communication amongst the interprofessional team to improve the outcome of patients affected with central serous chorioretinopathy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=96027&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=96027">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-96027.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Central serous chorioretinopathy (CSCR) is a retinal disorder characterized by localized serous detachment of the macula with or without focal serous pigment epithelial detachment (PED). It is mostly seen in young men aged 20&#x02013;45 years.<xref ref-type="bibr" rid="article-96027.r1">[1]</xref>&#x000a0;Albert V Graefe first described this condition as central recurrent retinitis in 1866. Bennet coined the term &#x0201c;central serous retinopathy,&#x0201d; and Gass described the pathogenesis.<xref ref-type="bibr" rid="article-96027.r2">[2]</xref>&#x000a0;The patient complains of distorted images, the apparent small size of objects, and blurred vision. Most of the cases resolve spontaneously in&#x000a0;3-6 months.<xref ref-type="bibr" rid="article-96027.r3">[3]</xref>&#x000a0;For non-resolving cases, treatment includes laser photocoagulation and photodynamic therapy.<xref ref-type="bibr" rid="article-96027.r4">[4]</xref><xref ref-type="bibr" rid="article-96027.r5">[5]</xref>&#x000a0;AntiVEGF and mineralocorticoid receptor antagonists have also been tried.<xref ref-type="bibr" rid="article-96027.r6">[6]</xref><xref ref-type="bibr" rid="article-96027.r7">[7]</xref><xref ref-type="bibr" rid="article-96027.r8">[8]</xref></p>
      </sec>
      <sec id="article-96027.s3" sec-type="Etiology">
        <title>Etiology</title>
        <list list-type="bullet">
          <list-item>
            <p>Yannuzzi suggested a relationship between CSCR and type A personality.<xref ref-type="bibr" rid="article-96027.r9">[9]</xref>&#x000a0;These persons are aggressive, competitive, and have a sense of urgency. Such behavior causes catecholamine release, which increases choroidal permeability.<xref ref-type="bibr" rid="article-96027.r10">[10]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Psychological stress and depression also predispose to CSCR.<xref ref-type="bibr" rid="article-96027.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>A definite association exists between CSCR and exogenous corticosteroid use.<xref ref-type="bibr" rid="article-96027.r12">[12]</xref><xref ref-type="bibr" rid="article-96027.r13">[13]</xref>&#x000a0;It is generally associated with systemic intake, either oral or intravenous.<xref ref-type="bibr" rid="article-96027.r13">[13]</xref><xref ref-type="bibr" rid="article-96027.r14">[14]</xref>&#x000a0;But studies have reported CSCR after nasal spray, topical skin creams, intra-articular, epidural, or periocular use.<xref ref-type="bibr" rid="article-96027.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>CSCR has also been reported following kidney, heart, and bone marrow transplantations.<xref ref-type="bibr" rid="article-96027.r16">[16]</xref><xref ref-type="bibr" rid="article-96027.r17">[17]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Increased endogenous cortisol production, such as Cushing disease and pregnancy, increases the risk of CSCR.<xref ref-type="bibr" rid="article-96027.r18">[18]</xref>&#x000a0;Steroid-effect might be an idiosyncratic response that affects vascular autoregulation.</p>
          </list-item>
          <list-item>
            <p>Drugs other than corticosteroids that have been associated with CSCR are
<list list-type="bullet"><list-item><p>oral MEK inhibitors</p></list-item><list-item><p>phosphodiesterase inhibitors</p></list-item><list-item><p>pseudoephedrine</p></list-item><list-item><p>oxymetazoline<xref ref-type="bibr" rid="article-96027.r17">[17]</xref><xref ref-type="bibr" rid="article-96027.r19">[19]</xref><xref ref-type="bibr" rid="article-96027.r20">[20]</xref><xref ref-type="bibr" rid="article-96027.r21">[21]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Association between&#x000a0;<italic toggle="yes">H. pylori</italic>&#x000a0;infection, peptic ulcer disease and CSCR has been reported in some studies.<xref ref-type="bibr" rid="article-96027.r22">[22]</xref><xref ref-type="bibr" rid="article-96027.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p>It is associated with stress and sleep disturbances. Treatment of the underlying cause resolves CSCR.<xref ref-type="bibr" rid="article-96027.r24">[24]</xref><xref ref-type="bibr" rid="article-96027.r25">[25]</xref><xref ref-type="bibr" rid="article-96027.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p>Familial association of CSCR has been reported.<xref ref-type="bibr" rid="article-96027.r27">[27]</xref><xref ref-type="bibr" rid="article-96027.r28">[28]</xref><xref ref-type="bibr" rid="article-96027.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p>Single nucleotide polymorphisms in complement factor H and cadherin 4 is thought to be associated.<xref ref-type="bibr" rid="article-96027.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>CSCR associated pachychoroid can be inherited as a dominant trait.<xref ref-type="bibr" rid="article-96027.r30">[30]</xref><xref ref-type="bibr" rid="article-96027.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p>Other systemic associations of CSCR include
<list list-type="bullet"><list-item><p>Sleep apnea syndrome</p></list-item><list-item><p>Systemic hypertension</p></list-item><list-item><p>Psychopharmacologic medications</p></list-item><list-item><p>Systemic lupus erythematosus<xref ref-type="bibr" rid="article-96027.r32">[32]</xref></p></list-item><list-item><p>Gastroesophageal reflux disease<xref ref-type="bibr" rid="article-96027.r24">[24]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-96027.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>CSCR is the fourth most common retinal disorder threatening the vision.<xref ref-type="bibr" rid="article-96027.r33">[33]</xref>&#x000a0;Men are commonly affected. The male-female ratio was found to be 6:1 in a population-based study.<xref ref-type="bibr" rid="article-96027.r34">[34]</xref>&#x000a0;The mean age group is 39-51 years.<xref ref-type="bibr" rid="article-96027.r34">[34]</xref><xref ref-type="bibr" rid="article-96027.r35">[35]</xref>&#x000a0;When females are affected, the age is usually higher than males. It is generally unilateral. However, bilateral involvement may be in up to 40% of cases.<xref ref-type="bibr" rid="article-96027.r36">[36]</xref>&#x000a0;However, the majority of cases have pigment epithelial detachment (PED) in the fellow eye also. Bilateral changes in the choroid are usually noted on optical coherence tomography (OCT)<xref ref-type="bibr" rid="article-96027.r37">[37]</xref> and indocyanine green angiography (ICGA).<xref ref-type="bibr" rid="article-96027.r37">[37]</xref>&#x000a0;Kitzmann et al. found the incidence of CSCR to be 9.9 cases per 100,000 population.<xref ref-type="bibr" rid="article-96027.r34">[34]</xref></p>
      </sec>
      <sec id="article-96027.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of CSCR is multifactorial, which causes retinal pigment epithelial (RPE) disturbances and circulatory changes in the choroid.<xref ref-type="bibr" rid="article-96027.r38">[38]</xref>&#x000a0;There is choroidal inflammation, which causes stasis and ischemia.<xref ref-type="bibr" rid="article-96027.r22">[22]</xref><xref ref-type="bibr" rid="article-96027.r38">[38]</xref><xref ref-type="bibr" rid="article-96027.r39">[39]</xref>&#x000a0;The choroidal vessels become hyperpermeable, and the choroid becomes thickened. This leads to increased tissue pressure, which disturbs the anatomic integrity of RPE and causes PED. The micro-defects in the RPE hamper its barrier functions. The choroidal fluid crosses the RPE and cause neurosensory detachment. It gets collected in the subretinal space. Another hypothesis is the loss of polarity of RPE.<xref ref-type="bibr" rid="article-96027.r40">[40]</xref>&#x000a0;</p>
        <p>Normally, the RPE keeps the retina in a dehydrated state by pumping out fluid from the subretinal space to the choroid. With the loss of polarity, the pumping reverses and fluid is directed towards the subretinal space. The non-perfusion in the choriocapillaris&#x000a0;may lead to the widening of venous channels and increased hydrostatic pressure.<xref ref-type="bibr" rid="article-96027.r22">[22]</xref><xref ref-type="bibr" rid="article-96027.r39">[39]</xref>&#x000a0;The mineralocorticoid receptor pathway has also been implicated.</p>
        <p>Experiments have shown that intravitreal injection of aldosterone causes dilatation of choroidal veins and congestion, which leads to the accumulation of fluid in the subretinal space.<xref ref-type="bibr" rid="article-96027.r41">[41]</xref>&#x000a0;The widespread choroidal hyperpermeability can be seen with indocyanine green angiography (ICGA).<xref ref-type="bibr" rid="article-96027.r38">[38]</xref>&#x000a0;Enhanced depth imaging optical coherence tomography (EDI-OCT) has demonstrated increased choroidal thickness and congestion.<xref ref-type="bibr" rid="article-96027.r42">[42]</xref>&#x000a0;On ICGA, areas of choroidal staining adjacent to the site of RPE leakage have been shown.<xref ref-type="bibr" rid="article-96027.r43">[43]</xref><xref ref-type="bibr" rid="article-96027.r44">[44]</xref></p>
      </sec>
      <sec id="article-96027.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The patient complains of unilateral blurred vision, micropsia, metamorphopsia, relative scotoma, and color vision disturbances. There is temporary hyperopia. Vision ranges from 6/9-6/60, though in most cases, it is better than 6/12. On examination, there is a well defined circular or oval area of neurosensory detachment over the posterior pole. Occasionally, a yellowish feathered-edge subretinal material (presumably fibrin) and PED may also be seen.<xref ref-type="bibr" rid="article-96027.r45">[45]</xref>&#x000a0;</p>
        <p>The acute episode generally resolves within 3&#x000a0;to 6 months. If fluid persists beyond this period, it is called &#x0201c;chronic CSCR.&#x0201d; It is generally seen in older patients or those receiving long term corticosteroids.<xref ref-type="bibr" rid="article-96027.r11">[11]</xref><xref ref-type="bibr" rid="article-96027.r46">[46]</xref>&#x000a0;Atypical CSCR presents as inferior bullous retinal detachment. Such cases may be associated with multifocal PED, multifocal neurosensory retinal detachments, and multiple leaks on fundus fluorescein angiogram (FFA).<xref ref-type="bibr" rid="article-96027.r47">[47]</xref></p>
      </sec>
      <sec id="article-96027.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Ancillary tests</p>
        <p>OCT (optical coherence tomography)</p>
        <p>This is the first line of investigation. The presence of subretinal fluid (SRF) is characteristic of CSCR. The resolution of SRF can be documented on serial OCT. Sometimes band-like fibrin deposits can be seen in the subretinal space.<xref ref-type="bibr" rid="article-96027.r48">[48]</xref>&#x000a0;Outer retinal dipping may be noted, which may touch the RPE or a PED.<xref ref-type="bibr" rid="article-96027.r49">[49]</xref>&#x000a0;The area of retinal dipping/sagging may denote the location of the leak.<xref ref-type="bibr" rid="article-96027.r49">[49]</xref>&#x000a0;In chronic CSCR intraretinal cystic changes, hyperreflective dots and elongated photoreceptor outer segments&#x000a0;may be present. CSCR is currently considered as part of the pachychoroid spectrum. Thicker choroid has been demonstrated on EDI OCT in eyes with CSCR and fellow eyes. Dilatation of outer choroidal vessels and thinning of choriocapillaris is present.<xref ref-type="bibr" rid="article-96027.r14">[14]</xref><xref ref-type="bibr" rid="article-96027.r18">[18]</xref><xref ref-type="bibr" rid="article-96027.r50">[50]</xref><xref ref-type="bibr" rid="article-96027.r51">[51]</xref>&#x000a0;PED is commonly seen. It is contiguous to areas of choroidal hyperpermeability, as evident on ICGA. Sometimes a double layer sign can be seen in chronic CSCR.<xref ref-type="bibr" rid="article-96027.r52">[52]</xref>&#x000a0;However, this sign is&#x000a0;typically seen in&#x000a0;idiopathic polypoidal choroidopathy (IPCV)<bold>.&#x000a0;</bold>IPCV and CSCR constitute the pachychoroid spectrum and ICGA helps in differentiating the two. Tiny white dots may be seen in CSCR on ophthalmoscopy, which appear as hyper-reflective dots in the outer retina on OCT.</p>
        <p>Fundus autofluorescence (FAF)</p>
        <p>In acute CSCR, focal areas of hypo-autofluorescence are seen&#x000a0;that may correspond&#x000a0;to the leak on FFA. In chronic CSCR, hyper-autofluorescent tracks are present due to the accumulation of photoreceptor pigments.</p>
        <p>Fundus fluorescein angiography (FFA)</p>
        <p>Three types of fluorescein leakage patterns are seen in CSCR- inkblot, smokestack, and diffuse. In the inkblot pattern, pinpoint leakage occurs in the early phase, which then concentrically enlarges in the late phase. In smokestack pattern, the leakage starts as a pinpoint and gradually expands to form an umbrella-like (or tree-like) appearance. Inkblot pattern is more common. In the diffuse leak, there are multiple small/inconspicuous leaks in a localized area, which cause an increase in the size and intensity of the area of hyper-fluorescence. In chronic CSCR, patchy areas of hyper-fluorescence are seen corresponding to areas of RPE atrophy. Serous PED shows early hyper-fluorescence with a progressive increase in the intensity, but size remains the same.</p>
        <p>Indocyanine green angiography (ICGA)</p>
        <p>ICGA is helpful in imaging the choroidal vasculature. It shows&#x000a0;hypocyanescence in the early phase denoting choriocapillaris nonperfusion and delayed filling. In mid-phase, hypercyanescence is seen, indicating choroidal vessel hyperpermeability. This hypercyanescence slowly fades in the late phase.<xref ref-type="bibr" rid="article-96027.r21">[21]</xref><xref ref-type="bibr" rid="article-96027.r22">[22]</xref><xref ref-type="bibr" rid="article-96027.r29">[29]</xref>&#x000a0;These changes are bilateral. ICGA also helps in the detection of a choroidal neovascularized membrane (CNVM) in chronic CSCR, which may occur in up to 23% of cases.<xref ref-type="bibr" rid="article-96027.r22">[22]</xref><xref ref-type="bibr" rid="article-96027.r53">[53]</xref></p>
        <p>OCT angiography (OCTA)</p>
        <p>It is useful in detecting CNVM in chronic CSCR by a non-invasive method. It shows dilated choriocapillaris in most eyes with CSCR.<xref ref-type="bibr" rid="article-96027.r34">[34]</xref>&#x000a0;Abnormal choroidal flow patterns suggestive of choroidal ischemia with surrounding hyperperfusion are seen in acute and chronic CSCR.<xref ref-type="bibr" rid="article-96027.r35">[35]</xref>&#x000a0;Dilated choroidal vessels are detected as high flow, well-delineated channels.<xref ref-type="bibr" rid="article-96027.r46">[46]</xref>&#x000a0;The SRF is seen as dark areas at the level of choriocapillaris. The PED is detected as dark spots. OCTA is being increasingly used to identity CNVM in CSCR and may detect CNVM in up to 20% cases of chronic CSCR.<xref ref-type="bibr" rid="article-96027.r53">[53]</xref></p>
      </sec>
      <sec id="article-96027.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The majority of cases of CSCR resolve spontaneously, so observation is done for 3-6 months.<xref ref-type="bibr" rid="article-96027.r22">[22]</xref>&#x000a0;In some cases, CSCR persists beyond 6 months or recurs. Chronic CSCR leads to macular degeneration, foveal atrophy, and RPE changes. In these cases, active treatment should be initiated.<xref ref-type="bibr" rid="article-96027.r54">[54]</xref>&#x000a0;If the patient is on steroids for a medical condition, then they should be discontinued and alternative therapy should be taken if possible. As CSCR of long duration may cause an irreversible visual decline, some clinicians may plan to treat early. Usually, for the first episode of CSCR, most clinicians observe (with reduction of stress/stoppage of steroids or other predisposing factors) for the initial few months as more than 80% cases resolve spontaneously.</p>
        <p>Indications for early intervention include</p>
        <list list-type="bullet">
          <list-item>
            <p>Visual demand of profession (pilot) or the patient for early recovery</p>
          </list-item>
          <list-item>
            <p>Recurrent disease</p>
          </list-item>
          <list-item>
            <p>Severe decline of vision in the other eye due to chronic CSCR</p>
          </list-item>
        </list>
        <p>Laser photocoagulation:</p>
        <p>The RPE leakage sites, as seen on angiography, can be treated with laser photocoagulation. Such therapy seals the leakage point and hastens the resolution of subretinal fluid.<xref ref-type="bibr" rid="article-96027.r55">[55]</xref>&#x000a0;The thermal laser is indicated for extrafoveal leakage points. A green-wavelength laser produces a light gray scar over the focal RPE leak. Spot size is 100 micrometers, duration &#x02264;0.1-second, and power ranging from 70-120 milliwatts is used. It should be applied judiciously as it may cause scotoma and laser-induced choroidal neovascularization.<xref ref-type="bibr" rid="article-96027.r55">[55]</xref><xref ref-type="bibr" rid="article-96027.r56">[56]</xref><xref ref-type="bibr" rid="article-96027.r57">[57]</xref><bold>&#x000a0;</bold>The laser&#x000a0;does not reduce the chances of recurrence.&#x000a0;To overcome these problems, a micropulse laser can be used.<xref ref-type="bibr" rid="article-96027.r58">[58]</xref><xref ref-type="bibr" rid="article-96027.r59">[59]</xref><xref ref-type="bibr" rid="article-96027.r60">[60]</xref><xref ref-type="bibr" rid="article-96027.r61">[61]</xref>&#x000a0;It is a diode or yellow laser which emits micropulses and delivers subthreshold laser energy without a visible burn. This stimulates the surrounding RPE cells and seals the defect. Some studies have reported faster visual recovery with this therapy.<xref ref-type="bibr" rid="article-96027.r62">[62]</xref><bold>&#x000a0;</bold></p>
        <p>Photodynamic therapy (PDT)</p>
        <p>CSCR with a subfoveal leak, juxtafoveal leak, multiple leaks, and chronic cases with diffuse decompensation of RPE are better managed with PDT. PDT causes vascular remodeling of the choroid and choroidal hypoperfusion.<xref ref-type="bibr" rid="article-96027.r63">[63]</xref><xref ref-type="bibr" rid="article-96027.r64">[64]</xref>&#x000a0;A drug called verteporfin is injected intravenously,&#x000a0;which then&#x000a0;reaches the eye. The verteporfin is activated by a laser on the source of leakage. This seals the RPE defect. It may also prevent future recurrences in some eyes. It appears to be a more effective treatment with a lower complication rate. Using EDI-OCT, the choroid can be monitored for thinning after treatment with PDT.<xref ref-type="bibr" rid="article-96027.r4">[4]</xref>&#x000a0;Low fluence PDT has improved efficacy and safety profile in chronic CSCR cases.<xref ref-type="bibr" rid="article-96027.r65">[65]</xref><xref ref-type="bibr" rid="article-96027.r66">[66]</xref></p>
        <p>Anti-vascular growth factor (VEGF):</p>
        <p>Anti VEGF therapy has been proposed to reduce choroidal hyperpermeability. They upregulate the tight junctions between endothelial cells and the reduction of vascular fenestrations.<xref ref-type="bibr" rid="article-96027.r67">[67]</xref><xref ref-type="bibr" rid="article-96027.r68">[68]</xref><xref ref-type="bibr" rid="article-96027.r69">[69]</xref>&#x000a0;Various studies have reported the effect of bevacizumab, ranibizumab, and aflibercept on CSCR.<xref ref-type="bibr" rid="article-96027.r70">[70]</xref><xref ref-type="bibr" rid="article-96027.r71">[71]</xref><xref ref-type="bibr" rid="article-96027.r72">[72]</xref>&#x000a0;Results remain inconclusive, and long term benefits warrant more studies. There is no level 1 or level 2 evidence for the use of anti-VEGF agents in CSCR though they have a definite role in CSCR related choroidal neovascularization or IPCV, which is a close differential diagnosis.</p>
        <p>Anti-corticosteroids</p>
        <p>Patients with CSCR commonly have endogenous hypercortisolism, thus drugs targeting cortisol pathways might be effective.<xref ref-type="bibr" rid="article-96027.r73">[73]</xref>&#x000a0;Ketoconazole is an antifungal agent which has anti glucocorticoid effects. It blocks the conversion of cholesterol to androgenic glucocorticoid end-products. Few studies have investigated ketoconazole as a treatment for CSCR without any significant benefit.<xref ref-type="bibr" rid="article-96027.r74">[74]</xref>&#x000a0;</p>
        <p>Mifepristone (RU-486) is an abortifacient agent. Its mechanism of action is mediated through its glucocorticoid and progesterone receptor antagonistic effects. It has been used in chronic CSCR patients with varied responses.<xref ref-type="bibr" rid="article-96027.r75">[75]</xref></p>
        <p>Finasteride is a weak anti-androgen that works through inhibiting type II 5 alpha-reductase that is necessary for converting testosterone to dihydrotestosterone (DHT), a potent androgen. It has been investigated in CSCR, but more trials are needed to evaluate the effect.<xref ref-type="bibr" rid="article-96027.r76">[76]</xref>&#x000a0;</p>
        <p>Eplerenone, a selective aldosterone-receptor antagonist and potassium-sparing diuretic, was originally approved in 2002 by the FDA for the treatment of hypertension. The medication is generally well-tolerated, but drug interactions must be ruled out prior to initiation, and serum potassium and blood pressure must be monitored during treatment. Studies have shown it to improve visual acuity and decrease central macular thickness in a small series of patients with chronic CSCR.<xref ref-type="bibr" rid="article-96027.r77">[77]</xref><xref ref-type="bibr" rid="article-96027.r78">[78]</xref><xref ref-type="bibr" rid="article-96027.r79">[79]</xref><xref ref-type="bibr" rid="article-96027.r80">[80]</xref>&#x000a0;Currently, its use in CSCR remains investigational and is not considered standard of care. Further studies are warranted to further clarify the role of aldosterone receptor antagonists in CSCR. A randomized control trial could not find the superiority of eplerenone to placebo in improving vision in chronic CSCR, and the authors recommended against its use for this indication.<xref ref-type="bibr" rid="article-96027.r81">[81]</xref></p>
        <p>Rifampicin is an anti-tuberculous medication that facilitates the catabolism of endogenous steroids. It increases the cytochrome P-450 content in the liver, thus affecting the metabolism and bioavailability of endogenous corticosteroids, consequently aiding in the resolution of CSCR and improving its symptomatology.<xref ref-type="bibr" rid="article-96027.r82">[82]</xref><xref ref-type="bibr" rid="article-96027.r83">[83]</xref><xref ref-type="bibr" rid="article-96027.r84">[84]</xref>&#x000a0;However, care is to be taken as hepatotoxicity can develop as a side effect while being treated for CSCR.</p>
        <p>Adrenergic blockers</p>
        <p>As CSCR is closely associated with type A personality, which is characterized by high adrenergic activity, it was proposed that blocking adrenergic receptors might have a positive effect on CSCR.<xref ref-type="bibr" rid="article-96027.r84">[84]</xref>&#x000a0;It has been shown that CSCR patients who were diagnosed&#x000a0;with hypertension and were started on metoprolol, a beta-blocker, had improved clinically.<xref ref-type="bibr" rid="article-96027.r85">[85]</xref><xref ref-type="bibr" rid="article-96027.r23">[23]</xref>&#x000a0;<xref ref-type="bibr" rid="article-96027.r85">[85]</xref>However, further assessment of the actual role of adrenergic blockers needs to be tested.</p>
        <p>Anti-<italic toggle="yes">Helicobacter pylori</italic> treatment</p>
        <p>The therapy of <italic toggle="yes">Helicobacter pylori</italic>-related peptic ulcer disease has shown variable results in CSCR.<xref ref-type="bibr" rid="article-96027.r23">[23]</xref>&#x000a0;However, peptic ulcer disease may be looked for in patients with chronic CSCR, and its management adds to the available therapy for chronic CSCR.</p>
      </sec>
      <sec id="article-96027.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other diseases of choroid and retina can closely mimic CSCR. They are ARMD (age-related macular degeneration), IPCV, and optic disc pit associated maculopathy. ARMD is seen in patients above 50 years. Chronic CSCR can develop secondary CNVM on follow up or after laser photocoagulation.</p>
        <p>OCT angiography is helpful in delineating the neovascular complex of ARMD. EDI OCT shows thicker choroid in CSCR and thin to normal choroid in ARMD. IPCV produces serous macular detachment and RPE changes similar to CSCR. The polyp and branching vascular network are characteristic findings on ICGA. OCT typically shows serosanguinous or notched PED.</p>
        <p>Optic disc pit causes serous macular detachment at the macula. On careful slit-lamp biomicroscopy, focal excavation can be seen on the temporal part of the optic disc. Retinal schisis is commonly observed in optic disc pit, while these changes are infrequently seen only in chronic CSCR. The sub-internal limiting membrane cavity after the resolution of sub-internal limiting membrane hemorrhage (including after Valsalva retinopathy) may simulate CSCR on cursory examination.<xref ref-type="bibr" rid="article-96027.r86">[86]</xref></p>
      </sec>
      <sec id="article-96027.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Most of the cases resolve spontaneously by 3-6 months. Some cases persist beyond 6 months. Such cases of chronic CSCR need treatment. Recurrence may be noted in up to 50% of untreated cases.<xref ref-type="bibr" rid="article-96027.r87">[87]</xref></p>
      </sec>
      <sec id="article-96027.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Chronic CSCR cases, if not treated, can have complications. Chronic CSCR with PED can develop RPE rip with secondary exudative retinal detachment. Such patients complain of sudden diminution of vision. Other complications can be CNVM and macular degeneration. Diffuse retinal pigment epitheliopathy in CSCR may be the cause of the irreversible visual decline.</p>
      </sec>
      <sec id="article-96027.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The patient should be counseled properly regarding the prognosis of CSCR. Acute idiopathic cases require observation&#x000a0;and avoidance of predisposing factors.</p>
      </sec>
      <sec id="article-96027.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Any patient presenting with CSCR should receive treatment by an ophthalmologist&#x000a0;and an interprofessional team evaluation by primary clinicians and endocrinologists. Interprofessional communication can lead to better patient management. The patient will most often present to the primary clinician, and these professionals should be aware of the condition as it is treatable. Prompt referral to an ophthalmologist is necessary.</p>
        <p>These patients can then be followed by their primary clinicians and should ensure compliance with treatment. Pharmacists can ensure correct dosing on the medication management aspect of the condition. Nursing will be the first&#x000a0;in the department to come in contact with patients on followup and can assess treatment progress as well as evaluate compliance with both medication and lifestyle measures, and report any issues to the primary care clinician. This collaborative, interprofessional approach to care can ensure optimal patient outcomes.</p>
      </sec>
      <sec id="article-96027.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=96027&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=96027">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/central-serous-chorioretinopathy-fluid-behind-the-retina/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=96027">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/96027/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=96027">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-96027.s15">
        <title>References</title>
        <ref id="article-96027.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis.</article-title>
            <source>Retina</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-19</page-range>
            <pub-id pub-id-type="pmid">26710181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of disciform detachment of the neuroepithelium.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1967</year>
            <month>Mar</month>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>Suppl:1</fpage>
            <page-range>Suppl:1-139</page-range>
            <pub-id pub-id-type="pmid">6019308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baran</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>G&#x000fc;rl&#x000fc;</surname>
                <given-names>VP</given-names>
              </name>
              <name>
                <surname>Esgin</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Long-term macular function in eyes with central serous chorioretinopathy.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>369</fpage>
            <page-range>369-72</page-range>
            <pub-id pub-id-type="pmid">16033348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maruko</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Iida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sugano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ojima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ogasawara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.</article-title>
            <source>Ophthalmology</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>117</volume>
            <issue>9</issue>
            <fpage>1792</fpage>
            <page-range>1792-9</page-range>
            <pub-id pub-id-type="pmid">20472289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taban</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boyer</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Taban</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Chronic central serous chorioretinopathy: photodynamic therapy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>137</volume>
            <issue>6</issue>
            <fpage>1073</fpage>
            <page-range>1073-80</page-range>
            <pub-id pub-id-type="pmid">15183792</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arevalo</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Espinoza</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>249</volume>
            <issue>8</issue>
            <fpage>1159</fpage>
            <page-range>1159-66</page-range>
            <pub-id pub-id-type="pmid">21448811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Artunay</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Yuzbasioglu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rasier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sengul</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bahcecioglu</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study.</article-title>
            <source>Curr Eye Res</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>91</fpage>
            <page-range>91-8</page-range>
            <pub-id pub-id-type="pmid">20136418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MU</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>249</volume>
            <issue>7</issue>
            <fpage>969</fpage>
            <page-range>969-74</page-range>
            <pub-id pub-id-type="pmid">21140161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Type A behavior and central serous chorioretinopathy.</article-title>
            <source>Trans Am Ophthalmol Soc</source>
            <year>1986</year>
            <volume>84</volume>
            <fpage>799</fpage>
            <page-range>799-845</page-range>
            <pub-id pub-id-type="pmid">3590481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Borodoker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Negrao</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cystoid macular degeneration in chronic central serous chorioretinopathy.</article-title>
            <source>Retina</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7; quiz 137-8</page-range>
            <pub-id pub-id-type="pmid">12652224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tittl</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pilotto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Systemic findings associated with central serous chorioretinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-8</page-range>
            <pub-id pub-id-type="pmid">10482095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carvalho-Recchia</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Negr&#x000e3;o</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Rodriguez-Coleman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lenharo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iida</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Corticosteroids and central serous chorioretinopathy.</article-title>
            <source>Ophthalmology</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>109</volume>
            <issue>10</issue>
            <fpage>1834</fpage>
            <page-range>1834-7</page-range>
            <pub-id pub-id-type="pmid">12359603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karadimas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kapetanios</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bouzas</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy after local application of glucocorticoids for skin disorders.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2004</year>
            <month>May</month>
            <volume>122</volume>
            <issue>5</issue>
            <fpage>784</fpage>
            <page-range>784-6</page-range>
            <pub-id pub-id-type="pmid">15136332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsai</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Leu</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.</article-title>
            <source>Retina</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>9</issue>
            <fpage>1867</fpage>
            <page-range>1867-74</page-range>
            <pub-id pub-id-type="pmid">24743638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daruich</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Matet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dirani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bousquet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jaisser</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Behar-Cohen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.</article-title>
            <source>Prog Retin Eye Res</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>48</volume>
            <fpage>82</fpage>
            <page-range>82-118</page-range>
            <pub-id pub-id-type="pmid">26026923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ulbig</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Riordan-Eva</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Holz</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Rees</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1993</year>
            <month>Oct</month>
            <day>15</day>
            <volume>116</volume>
            <issue>4</issue>
            <fpage>410</fpage>
            <page-range>410-3</page-range>
            <pub-id pub-id-type="pmid">8213970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Michael</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Pak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Venecia</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy associated with administration of sympathomimetic agents.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>136</volume>
            <issue>1</issue>
            <fpage>182</fpage>
            <page-range>182-5</page-range>
            <pub-id pub-id-type="pmid">12834690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haimovici</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gagnon</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Lehrfeld</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wellik</surname>
                <given-names>S</given-names>
              </name>
              <collab>Central Serous Chorioretinopathy Case-Control Study Group</collab>
            </person-group>
            <article-title>Risk factors for central serous chorioretinopathy: a case-control study.</article-title>
            <source>Ophthalmology</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>244</fpage>
            <page-range>244-9</page-range>
            <pub-id pub-id-type="pmid">15019370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCannel</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Chmielowski</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Finn</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ribas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wainberg</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>McCannel</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Bilateral subfoveal neurosensory retinal detachment associated with MEK inhibitor use for metastatic cancer.</article-title>
            <source>JAMA Ophthalmol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>132</volume>
            <issue>8</issue>
            <fpage>1005</fpage>
            <page-range>1005-9</page-range>
            <pub-id pub-id-type="pmid">24852144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aliferis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Petropoulos</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Farpour</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Matter</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Safran</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?</article-title>
            <source>Ophthalmologica</source>
            <year>2012</year>
            <volume>227</volume>
            <issue>2</issue>
            <fpage>85</fpage>
            <page-range>85-9</page-range>
            <pub-id pub-id-type="pmid">22156704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pierce</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy associated with the use of ephedra.</article-title>
            <source>Retin Cases Brief Rep</source>
            <year>2009</year>
            <season>Fall</season>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>376</fpage>
            <page-range>376-8</page-range>
            <pub-id pub-id-type="pmid">25389852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy: a personal perspective.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>149</volume>
            <issue>3</issue>
            <fpage>361</fpage>
            <page-range>361-363</page-range>
            <pub-id pub-id-type="pmid">20172062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Is Helicobacter pylori the culprit behind central serous chorioretinopathy?</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>254</volume>
            <issue>10</issue>
            <fpage>2069</fpage>
            <page-range>2069-2070</page-range>
            <pub-id pub-id-type="pmid">27364118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansuetta</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Swanner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Feist</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Thomley</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>McGwin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Emond</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>An association between central serous chorioretinopathy and gastroesophageal reflux disease.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>137</volume>
            <issue>6</issue>
            <fpage>1096</fpage>
            <page-range>1096-100</page-range>
            <pub-id pub-id-type="pmid">15183795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cotticelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Borrelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Alessio</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Menzione</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Villani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Piccolo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Montella</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Iovene</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy and Helicobacter pylori.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2006</year>
            <season>Mar-Apr</season>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>274</fpage>
            <page-range>274-8</page-range>
            <pub-id pub-id-type="pmid">16703546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misiuk-Hoj&#x00142;o</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Micha&#x00142;owska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Turno-Krecicka</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Helicobacter pylori--a risk factor for the developement of the central serous chorioretinopathy.</article-title>
            <source>Klin Oczna</source>
            <year>2009</year>
            <volume>111</volume>
            <issue>1-3</issue>
            <fpage>30</fpage>
            <page-range>30-2</page-range>
            <pub-id pub-id-type="pmid">19517842</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Arrigg</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>RY</given-names>
              </name>
            </person-group>
            <article-title>Familial central serous choroidopathy.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>238</volume>
            <issue>11</issue>
            <fpage>930</fpage>
            <page-range>930-1</page-range>
            <pub-id pub-id-type="pmid">11148819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oosterhuis</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Familial central serous retinopathy.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1996</year>
            <month>May</month>
            <volume>234</volume>
            <issue>5</issue>
            <fpage>337</fpage>
            <page-range>337-41</page-range>
            <pub-id pub-id-type="pmid">8740256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Schatz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gaffney</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Schaeffer</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy in two families.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>1998</year>
            <season>Jan-Mar</season>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-7</page-range>
            <pub-id pub-id-type="pmid">9590595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bousquet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Beydoun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Behar-Cohen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>PACHYCHOROID: an inherited condition?</article-title>
            <source>Retina</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-6</page-range>
            <pub-id pub-id-type="pmid">25046398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gass</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy and white subretinal exudation during pregnancy.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1991</year>
            <month>May</month>
            <volume>109</volume>
            <issue>5</issue>
            <fpage>677</fpage>
            <page-range>677-81</page-range>
            <pub-id pub-id-type="pmid">2025170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunningham</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Alfred</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Irvine</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy in patients with systemic lupus erythematosus.</article-title>
            <source>Ophthalmology</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>103</volume>
            <issue>12</issue>
            <fpage>2081</fpage>
            <page-range>2081-90</page-range>
            <pub-id pub-id-type="pmid">9003342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Munch</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Hasler</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Pr&#x000fc;nte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>126</fpage>
            <page-range>126-45</page-range>
            <pub-id pub-id-type="pmid">17662099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitzmann</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Pulido</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Diehl</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Burke</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.</article-title>
            <source>Ophthalmology</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>115</volume>
            <issue>1</issue>
            <fpage>169</fpage>
            <page-range>169-73</page-range>
            <pub-id pub-id-type="pmid">18166410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsai</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Leu</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.</article-title>
            <source>PLoS One</source>
            <year>2013</year>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>e66858</fpage>
            <pub-id pub-id-type="pmid">23826160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000e4;ckle</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Freissler</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>[Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects].</article-title>
            <source>Ophthalmologe</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>95</volume>
            <issue>8</issue>
            <fpage>529</fpage>
            <page-range>529-33</page-range>
            <pub-id pub-id-type="pmid">9782727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.</article-title>
            <source>Eye (Lond)</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>12</issue>
            <fpage>1635</fpage>
            <page-range>1635-40</page-range>
            <pub-id pub-id-type="pmid">22020172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pr&#x000fc;nte</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Flammer</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Choroidal capillary and venous congestion in central serous chorioretinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>121</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-34</page-range>
            <pub-id pub-id-type="pmid">8554078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Okushiba</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Study of choroidal vascular lesions in central serous chorioretinopathy using indocyanine green angiography].</article-title>
            <source>Nippon Ganka Gakkai Zasshi</source>
            <year>1997</year>
            <month>Jan</month>
            <volume>101</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-82</page-range>
            <pub-id pub-id-type="pmid">9028111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spitznas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of central serous retinopathy: a new working hypothesis.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>1986</year>
            <volume>224</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-4</page-range>
            <pub-id pub-id-type="pmid">3710187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>C&#x000e9;l&#x000e9;rier</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bousquet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jeanny</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Jonet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Savoldelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Offret</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Curan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farman</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jaisser</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Behar-Cohen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.</article-title>
            <source>J Clin Invest</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>122</volume>
            <issue>7</issue>
            <fpage>2672</fpage>
            <page-range>2672-9</page-range>
            <pub-id pub-id-type="pmid">22684104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jirarattanasopa</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ooto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsujikawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yamashiro</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hangai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hirata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matsumoto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.</article-title>
            <source>Ophthalmology</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>119</volume>
            <issue>8</issue>
            <fpage>1666</fpage>
            <page-range>1666-78</page-range>
            <pub-id pub-id-type="pmid">22521082</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matsunaga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography and pathophysiology of multifocal posterior pigment epitheliopathy.</article-title>
            <source>Retina</source>
            <year>1999</year>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-21</page-range>
            <pub-id pub-id-type="pmid">10048368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Klancnik</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Aizman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study.</article-title>
            <source>Retina</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>288</fpage>
            <page-range>288-98</page-range>
            <pub-id pub-id-type="pmid">12824827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>la Cour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics of subretinal deposits in central serous chorioretinopathy.</article-title>
            <source>Acta Ophthalmol Scand</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>83</volume>
            <issue>6</issue>
            <fpage>691</fpage>
            <page-range>691-6</page-range>
            <pub-id pub-id-type="pmid">16396646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spaide</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Campeas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Guyer</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Slakter</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sorenson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Orlock</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy in younger and older adults.</article-title>
            <source>Ophthalmology</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>103</volume>
            <issue>12</issue>
            <fpage>2070</fpage>
            <page-range>2070-9; discussion 2079-80</page-range>
            <pub-id pub-id-type="pmid">9003341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balaratnasingam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mrejen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hunyor</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Keegan</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Dansingani</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Dayani</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Barbazetto</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Sarraf</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging.</article-title>
            <source>Ophthalmology</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>123</volume>
            <issue>7</issue>
            <fpage>1541</fpage>
            <page-range>1541-52</page-range>
            <pub-id pub-id-type="pmid">27084564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imasawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ohshiro</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gotoh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Imai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iijima</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy following vitrectomy with intravitreal triamcinolone acetonide for diabetic macular oedema.</article-title>
            <source>Acta Ophthalmol Scand</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>83</volume>
            <issue>1</issue>
            <fpage>132</fpage>
            <page-range>132-3</page-range>
            <pub-id pub-id-type="pmid">15715582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography.</article-title>
            <source>Korean J Ophthalmol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>347</fpage>
            <page-range>347-54</page-range>
            <pub-id pub-id-type="pmid">23060721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haimovici</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gragoudas</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Duker</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Sjaarda</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Eliott</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids.</article-title>
            <source>Ophthalmology</source>
            <year>1997</year>
            <month>Oct</month>
            <volume>104</volume>
            <issue>10</issue>
            <fpage>1653</fpage>
            <page-range>1653-60</page-range>
            <pub-id pub-id-type="pmid">9331207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kleinberger</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lieberman</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Malkin</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.</article-title>
            <source>Laryngoscope</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>121</volume>
            <issue>9</issue>
            <fpage>2034</fpage>
            <page-range>2034-7</page-range>
            <pub-id pub-id-type="pmid">22024860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jonas</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2013</year>
            <month>Jul</month>
            <day>12</day>
            <volume>54</volume>
            <issue>7</issue>
            <fpage>4659</fpage>
            <page-range>4659-65</page-range>
            <pub-id pub-id-type="pmid">23737472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stattin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Forster</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Glittenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Herrmann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krebs</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ansari-Shahrezaei</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Detection of secondary choroidal neovascularization in chronic central serous chorioretinopathy by swept source-optical coherence tomography angiography.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>97</volume>
            <issue>1</issue>
            <fpage>e135</fpage>
            <page-range>e135-e136</page-range>
            <pub-id pub-id-type="pmid">30284407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Retinal atrophy in idiopathic central serous chorioretinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>6</issue>
            <fpage>787</fpage>
            <page-range>787-93</page-range>
            <pub-id pub-id-type="pmid">12036670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>4</issue>
            <fpage>514</fpage>
            <page-range>514-7</page-range>
            <pub-id pub-id-type="pmid">20644214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robertson</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Ilstrup</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>95</volume>
            <issue>4</issue>
            <fpage>457</fpage>
            <page-range>457-66</page-range>
            <pub-id pub-id-type="pmid">6682293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000e4;rtner</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up of an ophthalmologist's central serous retinopathy, photocoagulated by sungazing.</article-title>
            <source>Doc Ophthalmol</source>
            <year>1987</year>
            <month>May</month>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>19</fpage>
            <page-range>19-33</page-range>
            <pub-id pub-id-type="pmid">3428072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sivaprasad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elagouz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McHugh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shona</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dorin</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Micropulsed diode laser therapy: evolution and clinical applications.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2010</year>
            <season>Nov-Dec</season>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>516</fpage>
            <page-range>516-30</page-range>
            <pub-id pub-id-type="pmid">20850854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Elagouz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McHugh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sivaprasad</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Micropulse diode laser photocoagulation for central serous chorio-retinopathy.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>801</fpage>
            <page-range>801-5</page-range>
            <pub-id pub-id-type="pmid">19878226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage.</article-title>
            <source>Ophthalmology</source>
            <year>2008</year>
            <month>Dec</month>
            <volume>115</volume>
            <issue>12</issue>
            <fpage>2229</fpage>
            <page-range>2229-34</page-range>
            <pub-id pub-id-type="pmid">19041477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lanzetta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Furlan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Morgante</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Veritti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bandello</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2008</year>
            <season>Nov-Dec</season>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>934</fpage>
            <page-range>934-40</page-range>
            <pub-id pub-id-type="pmid">18988165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tewari</surname>
                <given-names>HK</given-names>
              </name>
            </person-group>
            <article-title>Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial [ISRCTN84128484].</article-title>
            <source>BMC Ophthalmol</source>
            <year>2004</year>
            <month>Oct</month>
            <day>29</day>
            <volume>4</volume>
            <fpage>15</fpage>
            <pub-id pub-id-type="pmid">15516262</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>RY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.</article-title>
            <source>Ophthalmology</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>115</volume>
            <issue>10</issue>
            <fpage>1756</fpage>
            <page-range>1756-65</page-range>
            <pub-id pub-id-type="pmid">18538401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt-Erfurth</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Laqua</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schl&#x000f6;tzer-Schrehard</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Viestenz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Naumann</surname>
                <given-names>GO</given-names>
              </name>
            </person-group>
            <article-title>Histopathological changes following photodynamic therapy in human eyes.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>120</volume>
            <issue>6</issue>
            <fpage>835</fpage>
            <page-range>835-44</page-range>
            <pub-id pub-id-type="pmid">12049594</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alcubierre</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arias</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lorenzo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pujol</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Rubio</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Low-fluence photodynamic therapy in chronic central serous chorioretinopathy].</article-title>
            <source>Arch Soc Esp Oftalmol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>87</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-8</page-range>
            <pub-id pub-id-type="pmid">22248651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Butler</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Fung</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Merkur</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Albiani</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Forooghian</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Very minimal fluence photodynamic therapy for chronic central serous chorioretinopathy.</article-title>
            <source>Can J Ophthalmol</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-4</page-range>
            <pub-id pub-id-type="pmid">22333850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Witkin</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Update on nonsurgical therapy for diabetic macular edema.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2011</year>
            <month>May</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>185</fpage>
            <page-range>185-9</page-range>
            <pub-id pub-id-type="pmid">21427573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Regillo</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>Preferred therapies for neovascular age-related macular degeneration.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2011</year>
            <month>May</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-204</page-range>
            <pub-id pub-id-type="pmid">21427571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>London</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Update and review of central retinal vein occlusion.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2011</year>
            <month>May</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>159</fpage>
            <page-range>159-65</page-range>
            <pub-id pub-id-type="pmid">21460724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>143</volume>
            <issue>6</issue>
            <fpage>977</fpage>
            <page-range>977-983</page-range>
            <pub-id pub-id-type="pmid">17459318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Konstantinidis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mantel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zografos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ambresin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2010</year>
            <season>Sep-Oct</season>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>955</fpage>
            <page-range>955-8</page-range>
            <pub-id pub-id-type="pmid">20306440</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broadhead</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>253</volume>
            <issue>6</issue>
            <fpage>979</fpage>
            <page-range>979-81</page-range>
            <pub-id pub-id-type="pmid">25547617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Weinreb</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yannuzzi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies.</article-title>
            <source>Ophthalmology</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>109</volume>
            <issue>10</issue>
            <fpage>1765</fpage>
            <page-range>1765-6</page-range>
            <pub-id pub-id-type="pmid">12359592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Golshahi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Klingm&#x000fc;ller</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Holz</surname>
                <given-names>FG</given-names>
              </name>
              <name>
                <surname>Eter</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Ketoconazole in the treatment of central serous chorioretinopathy: a pilot study.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>576</fpage>
            <page-range>576-81</page-range>
            <pub-id pub-id-type="pmid">19456313</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nielsen</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Jampol</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Oral mifepristone for chronic central serous chorioretinopathy.</article-title>
            <source>Retina</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>9</issue>
            <fpage>1928</fpage>
            <page-range>1928-36</page-range>
            <pub-id pub-id-type="pmid">21878843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forooghian</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Meleth</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Cukras</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chew</surname>
                <given-names>EY</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Meyerle</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Finasteride for chronic central serous chorioretinopathy.</article-title>
            <source>Retina</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>766</fpage>
            <page-range>766-71</page-range>
            <pub-id pub-id-type="pmid">21273946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bousquet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Beydoun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Offret</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Behar-Cohen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study.</article-title>
            <source>Retina</source>
            <year>2013</year>
            <season>Nov-Dec</season>
            <volume>33</volume>
            <issue>10</issue>
            <fpage>2096</fpage>
            <page-range>2096-102</page-range>
            <pub-id pub-id-type="pmid">23719402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stumpfe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feucht</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Strobl</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rath</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lohmann</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>[Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy].</article-title>
            <source>Ophthalmologe</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>173</fpage>
            <page-range>173-80</page-range>
            <pub-id pub-id-type="pmid">24510173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Breukink</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Keunen</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Boon</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Hoyng</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy.</article-title>
            <source>Acta Ophthalmol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>92</volume>
            <issue>6</issue>
            <fpage>e488</fpage>
            <page-range>e488-90</page-range>
            <pub-id pub-id-type="pmid">24698599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gruszka</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report.</article-title>
            <source>Eur Rev Med Pharmacol Sci</source>
            <year>2013</year>
            <month>May</month>
            <volume>17</volume>
            <issue>10</issue>
            <fpage>1369</fpage>
            <page-range>1369-73</page-range>
            <pub-id pub-id-type="pmid">23740451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lotery</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sivaprasad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Culliford</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cree</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Madhusudhan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Behar-Cohen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chakravarthy</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Peto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>BC</given-names>
              </name>
              <collab>VICI trial investigators</collab>
            </person-group>
            <article-title>Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial.</article-title>
            <source>Lancet</source>
            <year>2020</year>
            <month>Jan</month>
            <day>25</day>
            <volume>395</volume>
            <issue>10220</issue>
            <fpage>294</fpage>
            <page-range>294-303</page-range>
            <pub-id pub-id-type="pmid">31982075</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinle</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Oral rifampin utilisation for the treatment of chronic multifocal central serous retinopathy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-3</page-range>
            <pub-id pub-id-type="pmid">22053102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ravage</surname>
                <given-names>ZB</given-names>
              </name>
              <name>
                <surname>Packo</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Creticos</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Merrill</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>Chronic central serous chorioretinopathy responsive to rifampin.</article-title>
            <source>Retin Cases Brief Rep</source>
            <year>2012</year>
            <season>Winter</season>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>129</fpage>
            <page-range>129-32</page-range>
            <pub-id pub-id-type="pmid">25390732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tatham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Macfarlane</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The use of propranolol to treat central serous chorioretinopathy: an evaluation by serial OCT.</article-title>
            <source>J Ocul Pharmacol Ther</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-9</page-range>
            <pub-id pub-id-type="pmid">16722801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Avci</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Deutman</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>[Treatment of central serous choroidopathy with the beta receptor blocker metoprolol (preliminary results)].</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>202</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-205</page-range>
            <pub-id pub-id-type="pmid">8510413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vekaria</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>YR</given-names>
              </name>
            </person-group>
            <article-title>Sub-internal Limiting Membrane Cavity Following Valsalva Retinopathy Resembling Central Serous Chorioretinopathy.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2018</year>
            <season>Jan-Mar</season>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-84</page-range>
            <pub-id pub-id-type="pmid">29403598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-96027.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gilbert</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Owens</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up of central serous chorioretinopathy.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1984</year>
            <month>Nov</month>
            <volume>68</volume>
            <issue>11</issue>
            <fpage>815</fpage>
            <page-range>815-20</page-range>
            <pub-id pub-id-type="pmid">6541945</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
